Europa-Marktprognose für Neurostimulationsgeräte bis 2030 – regionale Analyse – nach Produkt (Rückenmarksstimulator, Tiefenhirnstimulator, Sakralnervenstimulator, Vagusnervstimulator und andere), Anwendung (Schmerzbehandlung, Epilepsie, Harn- und Stuhlinkontinenz, Parkinson). Krankheiten und andere) und Endbenutzer (Krankenhäuser, Spezialkliniken und andere)

Der europäische Markt für Neurostimulationsgeräte wurde im Jahr 2022 auf 1.717,84 Millionen US-Dollar geschätzt und wird bis 2030 voraussichtlich 3.459,24 Millionen US-Dollar erreichen; Von 2022 bis 2030 wird eine durchschnittliche jährliche Wachstumsrate von 9,1 % erwartet. Steigende Fälle von Rückenmarksverletzungen befeuern den Markt für Neurostimulationsgeräte in Europa. Die Branche der Neurostimulationsgeräte hat aufgrund der wachsenden Zahl älterer Menschen, die anfällig für verschiedene Wirbelsäulenerkrankungen sind, an Bedeutung gewonnen. Diese Bevölkerungsgruppe wird immer anfälliger für die Entwicklung von Wirbelsäulenerkrankungen wie degenerativen Bandscheibenerkrankungen, Arthrose, Skoliose, Wirbelsäulentumoren und Wirbelsäulenstenosen. Mit zunehmendem Alter dieser Bevölkerung kann die natürliche Abnutzung der Wirbelsäule zu verschiedenen Wirbelsäulenerkrankungen führen. Vor diesem Hintergrund stellt die alternde Bevölkerung eine besondere Herausforderung für Wirbelsäulenchirurgen dar, da sie mehrfach gebrechlich ist, medizinische Komorbiditäten aufweist, sich der Ernährungszustand verschlechtert und die Wahrscheinlichkeit postoperativer Komplikationen höher ist. Den im Oktober 2022 veröffentlichten Daten der Weltgesundheitsorganisation (WHO) zufolge werden im Jahr 2050 etwa 80 % der älteren Bevölkerung in Ländern mit niedrigem und mittlerem Einkommen leben, und es wird erwartet, dass diese Bevölkerungsalterung deutlich schneller voranschreiten wird schneller als in der Vergangenheit. Die alternde Bevölkerungsgruppe hat in Verbindung mit Lebensstilfaktoren zu einem erheblichen Anstieg der Menschen mit Wirbelsäulenproblemen wie degenerativen Bandscheibenerkrankungen und Wirbelsäulendeformitäten geführt. Daher stimuliert die hohe Inzidenz von Rückenmarksverletzungen im Alter und bei Erwachsenen die Nachfrage nach Neurostimulationsgeräten. Überblick über den europäischen Markt für Neurostimulationsgeräte Der europäische Markt für Neurostimulationsgeräte ist in Großbritannien, Deutschland, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Es wird erwartet, dass der regionale Markt in den kommenden Jahren aufgrund der steigenden Prävalenz neurologischer Erkrankungen wie zerebraler Aneurysmen, Schlaganfall und anderer sowie zunehmender Produktinnovationen der in der Region tätigen Marktteilnehmer erheblich wachsen wird. Das Marktwachstum ist auch auf die Entwicklung von Gesundheitssystemen in Ländern wie Deutschland, Frankreich und Spanien sowie auf die Zunahme innovativer Produkteinführungen wichtiger regionaler Unternehmen zurückzuführen. Im Juni 2020 gab Medtronic die Einführung des PerceptTM PC Neurostimulators mit BrainsenseTM-Technologie bekannt. Die Technologie zeichnet gleichzeitig elektrische Stimulationen auf und leitet sie an das Gehirn weiter, um die Symptome der Parkinson-Krankheit (PD) zu lindern. Umsatz und Prognose des Marktes für Neurostimulationsgeräte in Europa bis 2030 (in Mio. US-Dollar) Marktsegmentierung für Neurostimulationsgeräte in Europa Der Markt für Neurostimulationsgeräte in Europa ist nach Produkt, Anwendung, Endbenutzer und Land segmentiert. Je nach Produkt ist der europäische Markt für Neurostimulationsgeräte in Rückenmarksstimulatoren, Tiefenhirnstimulatoren, Sakralnervenstimulatoren, Vagusnervstimulatoren und andere unterteilt. Das Segment der Rückenmarksstimulatoren hatte im Jahr 2022 den größten Marktanteil. Hinsichtlich der Anwendung ist der europäische Markt für Neurostimulationsgeräte in Schmerzbehandlung, Epilepsie, Harn- und Stuhlinkontinenz, Parkinson-Krankheit und andere unterteilt. Das Segment Schmerzmanagement hatte im Jahr 2022 den größten Marktanteil. Nach Endverbrauchern ist der europäische Markt für Neurostimulationsgeräte in Krankenhäuser, Spezialkliniken und andere unterteilt. Das Segment Krankenhäuser hatte im Jahr 2022 den größten Marktanteil. Je nach Land ist der europäische Markt für Neurostimulationsgeräte in Großbritannien, Deutschland, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Deutschland dominierte im Jahr 2022 den europäischen Markt für Neurostimulationsgeräte. Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc und Mainstay Medical sind einige der führenden Unternehmen, die auf dem europäischen Markt für Neurostimulationsgeräte tätig sind .

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Synapse Biomedical Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 ElectroCore Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Mainstay Medical

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 12. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 13. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Synapse Biomedical Inc

7. ElectroCore Inc

8. Mainstay Medical

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe neurostimulation devices market.

Highlights key business priorities in order to assist companies to realign their business strategies

The key findings and recommendations highlight crucial progressive industry trends in the Europe neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe neurostimulation devices market, as well as those hindering it

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For Europe Neurostimulation Devices Market

WHAT'S INCLUDED IN FULL REPORT